Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies said today that Anthem has issued a positive coverage decision for its US Food and Drug Administration-cleared Prosigna breast cancer assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.